About the Company - Bal Pharma Ltd
Bal Pharma Ltd. is a Public Limited Listed company incorporated on 19/05/1987 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1987PLC008368 and registration number is 008368. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 280.37 Cr. and Equity Capital is Rs. 14.82 Cr. for the Year ended 31/03/2022.
| Management |
|---|
| Name | Position Held |
|---|
| Mr. Shailesh D Siroya | Managing Director |
| Mr. Himesh Virupakshaya | Executive Director |
| Mr. Jatish Sheth | Independent Director |
| Dr. C V Srinivas | Independent Director |
| Ms. Nicloa Neeladri | Independent Director |
| Mr. H S Venkatesh | Additional Director |
| Mr. Kotian Chittananda Damodar | Additional Director |
Bal Pharma Ltd. Share Price Update |
|---|
| Share Price | Value |
|---|
| Today | ₹103.00 |
| Previous Day | ₹104.36 |
Basic Stock Data of Bal Pharma Ltd
| Market Cap | 166 Cr. |
|---|
| Current Price | 105 |
|---|
| High / Low | 118/63.4 |
|---|
| Stock P/E | 51.7 |
|---|
| Book Value | 40.3 |
|---|
| Dividend Yield | 0.97 % |
|---|
| ROCE | 9.56 % |
|---|
| ROE | 4.20 % |
|---|
| Face Value | 10.0 |
|---|
Bal Pharma Ltd Quarterly Results
Bal Pharma Ltd Quarterly Chart
Bal Pharma Ltd Profit & Loss
| Month | Mar 2010 | Mar 2011 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|
| Sales | 106 | 114 | 179 | 187 | 198 | 229 | 211 | 225 | 171 | 251 | 281 | 304 | 305 |
| Expenses | 103 | 104 | 161 | 170 | 183 | 214 | 194 | 207 | 166 | 226 | 257 | 279 | 278 |
| Operating Profit | 3 | 10 | 18 | 17 | 15 | 15 | 17 | 18 | 5 | 25 | 24 | 25 | 27 |
| OPM % | 3% | 9% | 10% | 9% | 7% | 6% | 8% | 8% | 3% | 10% | 9% | 8% | 9% |
| Other Income | 5 | 1 | 1 | 1 | 1 | 3 | 2 | 1 | 2 | 1 | 5 | 1 | 1 |
| Interest | 6 | 7 | 7 | 7 | 6 | 8 | 9 | 13 | 13 | 12 | 11 | 12 | 13 |
| Depreciation | 3 | 3 | 5 | 7 | 7 | 6 | 7 | 6 | 8 | 10 | 9 | 9 | 9 |
| Profit before tax | -1 | 1 | 7 | 5 | 3 | 3 | 3 | -0 | -14 | 4 | 9 | 5 | 4 |
| Tax % | -57% | 60% | 23% | 25% | 90% | 114% | 87% | 1,175% | 5% | -15% | 38% | 45% | |
| Net Profit | -1 | 0 | 5 | 4 | 1 | -0 | 0 | 2 | -13 | 5 | 6 | 3 | 2 |
| EPS in Rs | -1.36 | 0.39 | 4.56 | 2.82 | 1.10 | 1.24 | 1.96 | 2.67 | -8.62 | 3.20 | 3.78 | 1.64 | 1.50 |
| Dividend Payout % | 0% | 0% | 22% | 35% | 91% | 81% | 51% | 37% | 0% | 31% | 26% | 61% | |
Bal Pharma Ltd Profit & Loss Yearly Chart
Bal Pharma Ltd Growth
|
| Compounded Sales Growth |
|---|
| 10 Years:: | % |
| 5 Years:: | 8% |
| 3 Years:: | 21% |
| TTM:: | 12% |
Bal Pharma Ltd Growth
|
| Compounded Profit Growth |
|---|
| 10 Years:: | % |
| 5 Years:: | 47% |
| 3 Years:: | 30% |
| TTM:: | 13% |
Bal Pharma Ltd Growth
|
| Stock Price CAGR |
|---|
| 10 Years:: | 17% |
| 5 Years:: | 6% |
| 3 Years:: | 24% |
| 1 Year:: | 18% |
Bal Pharma Ltd Growth
|
| Return on Equity |
|---|
| 10 Years:: | % |
| 5 Years:: | 1% |
| 3 Years:: | 7% |
| Last Year:: | 4% |
Bal Pharma Ltd Balance Sheet
| Month | Mar 2010 | Mar 2011 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 |
|---|
| Equity Capital | 10 | 10 | 11 | 13 | 13 | 14 | 14 | 14 | 14 | 15 | 15 | 16 | 16 |
| Reserves | 25 | 26 | 37 | 40 | 40 | 48 | 51 | 52 | 38 | 39 | 43 | 48 | 48 |
| Borrowings | 54 | 58 | 51 | 49 | 89 | 93 | 110 | 124 | 118 | 110 | 104 | 131 | 141 |
| Other Liabilities | 34 | 41 | 56 | 61 | 69 | 78 | 86 | 71 | 68 | 76 | 99 | 116 | 126 |
| Total Liabilities | 124 | 135 | 155 | 164 | 211 | 233 | 260 | 261 | 238 | 240 | 261 | 311 | 330 |
| Fixed Assets | 50 | 48 | 55 | 52 | 56 | 60 | 71 | 70 | 71 | 69 | 67 | 76 | 76 |
| CWIP | 0 | 0 | 0 | 1 | 4 | 2 | 0 | 4 | 3 | 0 | 2 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 74 | 87 | 99 | 111 | 151 | 172 | 188 | 187 | 164 | 172 | 192 | 235 | 254 |
| Total Assets | 124 | 135 | 155 | 164 | 211 | 233 | 260 | 261 | 238 | 240 | 261 | 311 | 330 |
Bal Pharma Ltd Reserves and Borrowings Chart
Bal Pharma Ltd Cash Flow
| Month | Mar 2010 | Mar 2011 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|
| Cash from Operating Activity | -5 | 5 | 13 | 15 | -19 | 6 | 1 | 8 | 23 | 22 | 27 | -2 |
| Cash from Investing Activity | 5 | -2 | -7 | -5 | -14 | -8 | -4 | -8 | -5 | -6 | -9 | -22 |
| Cash from Financing Activity | 1 | -2 | -8 | -7 | 32 | -6 | 4 | 0 | -20 | -17 | -17 | 24 |
| Net Cash Flow | 0 | 1 | -2 | 2 | -1 | -8 | 1 | -0 | -2 | 0 | 0 | 0 |
|
Bal Pharma Ltd Financial Efficiency Indicators Chart
No valid data available for the Shareholding
Bal Pharma Ltd Shareholding Pattern Chart
No. of Bal Pharma Ltd Shareholders
This stock is not held by any mutual fund
Bal Pharma Ltd ROCE Trend
Bal Pharma Ltd Key Financial Ratios
| Month | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 |
|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.67 | 3.79 | 3.34 | -9.10 | 1.52 |
| Diluted EPS (Rs.) | 1.68 | 3.79 | 3.34 | -9.10 | 1.52 |
| Cash EPS (Rs.) | 7.49 | 9.95 | 9.60 | -3.68 | 5.86 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 40.60 | 39.46 | 35.99 | 31.99 | 42.49 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 40.60 | 39.46 | 35.99 | 31.99 | 42.49 |
| Revenue From Operations / Share (Rs.) | 193.89 | 189.72 | 169.02 | 120.72 | 158.77 |
| PBDIT / Share (Rs.) | 16.61 | 19.31 | 17.27 | 4.66 | 13.06 |
| PBIT / Share (Rs.) | 10.79 | 13.21 | 10.85 | -0.75 | 8.72 |
| PBT / Share (Rs.) | 3.03 | 6.20 | 2.77 | -9.55 | -0.14 |
| Net Profit / Share (Rs.) | 1.67 | 3.85 | 3.18 | -9.10 | 1.52 |
| NP After MI And SOA / Share (Rs.) | 1.64 | 3.79 | 3.20 | -8.62 | 2.67 |
| PBDIT Margin (%) | 8.56 | 10.18 | 10.21 | 3.85 | 8.22 |
| PBIT Margin (%) | 5.56 | 6.96 | 6.41 | -0.62 | 5.49 |
| PBT Margin (%) | 1.56 | 3.26 | 1.63 | -7.90 | -0.08 |
| Net Profit Margin (%) | 0.86 | 2.02 | 1.88 | -7.53 | 0.95 |
| NP After MI And SOA Margin (%) | 0.84 | 1.99 | 1.89 | -7.14 | 1.68 |
| Return on Networth / Equity (%) | 4.03 | 9.57 | 8.85 | -23.30 | 5.68 |
| Return on Capital Employeed (%) | 16.30 | 20.64 | 18.36 | -1.36 | 12.60 |
| Return On Assets (%) | 0.82 | 2.15 | 1.97 | -5.12 | 1.44 |
| Long Term Debt / Equity (X) | 0.47 | 0.46 | 0.44 | 0.44 | 0.43 |
| Total Debt / Equity (X) | 2.05 | 1.67 | 1.95 | 2.15 | 1.74 |
| Asset Turnover Ratio (%) | 1.01 | 1.06 | 0.99 | 0.68 | 0.86 |
| Current Ratio (X) | 1.09 | 1.11 | 1.08 | 1.01 | 1.11 |
| Quick Ratio (X) | 0.62 | 0.66 | 0.68 | 0.58 | 0.68 |
| Inventory Turnover Ratio (X) | 2.08 | 2.43 | 2.12 | 1.05 | 1.67 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 26.41 | 0.00 | -11.59 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 10.11 | 0.00 | -31.21 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 73.59 | 0.00 | 111.59 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 89.89 | 0.00 | 131.21 | 0.00 |
| Interest Coverage Ratio (%) | 2.14 | 2.75 | 2.14 | 0.53 | 1.47 |
| Interest Coverage Ratio (Post Tax) (%) | 1.21 | 1.55 | 1.39 | -0.03 | 1.17 |
| Enterprise Value (Cr.) | 228.31 | 252.09 | 180.34 | 148.68 | 205.00 |
| EV / Net Operating Revenue (X) | 0.75 | 0.89 | 0.71 | 0.86 | 0.91 |
| EV / EBITDA (X) | 8.76 | 8.81 | 7.05 | 22.53 | 11.07 |
| MarketCap / Net Operating Revenue (X) | 0.34 | 0.56 | 0.31 | 0.26 | 0.44 |
| Retention Ratios (%) | 0.00 | 73.58 | 0.00 | 111.59 | 0.00 |
| Price / BV (X) | 1.65 | 2.73 | 1.49 | 0.87 | 1.50 |
| Price / Net Operating Revenue (X) | 0.34 | 0.56 | 0.31 | 0.26 | 0.44 |
| EarningsYield | 0.02 | 0.03 | 0.05 | -0.26 | 0.03 |
Bal Pharma Ltd Profitability Ratios (%)
Bal Pharma Ltd Liquidity Ratios
Bal Pharma Ltd Liquidity Ratios (%)
Bal Pharma Ltd Interest Coverage Ratios (%)
Bal Pharma Ltd Valuation Ratios
Fair Value of Bal Pharma Ltd Stock
Fair Value: ₹88.36
The stock is overvalued by 15.85% compared to the current price ₹105
*This is not Investment Advice
Strength and Weakness of Bal Pharma Ltd Stock
Unable to fetch valid data for stock valuation.
